相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
Hamzah Abu-Sbeih et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events Understanding the Upside of the Downside of Checkpoint Blockade
Diwakar Davar et al.
JAMA ONCOLOGY (2019)
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials A Systematic Review and Meta-analysis
Yucai Wang et al.
JAMA ONCOLOGY (2019)
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer
Fiamma Berner et al.
JAMA ONCOLOGY (2019)
Melanoma Among Non-Hispanic Black Americans
MaryBeth B. Culp et al.
PREVENTING CHRONIC DISEASE (2019)
Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational Burden
David Bomze et al.
JAMA ONCOLOGY (2019)
Ipilimumab-induced Adenohypophysitis and Orbital Apex Syndrome: Importance of Early Diagnosis and Management
Bahareh Hassanzadeh et al.
NEURO-OPHTHALMOLOGY (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The 2016 American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Database Characteristics and Methods
Michael F. Chiang et al.
OPHTHALMOLOGY (2018)
CHECKPOINT INHIBITOR IMMUNE THERAPY Systemic Indications and Ophthalmic Side Effects
Lauren A. Dalvin et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2018)
Recurrent anterior uveitis and subsequent incidence of ankylosing spondylitis: a nationwide cohort study from 2002 to 2013
Baek-Lok Oh et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
A. M. Menzies et al.
ANNALS OF ONCOLOGY (2017)
Safety of treatment with nivolumab after ipilimumab-related meningoradiculitis and bilateral optic neuropathy
W. Boisseau et al.
EUROPEAN JOURNAL OF CANCER (2017)
Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
Hans J. Hammers et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Inflammatory Orbitopathy Associated With Ipilimumab
Claire A. Sheldon et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2017)
Immune system and melanoma biology: a balance between immunosurveillance and immune escape
Anna Passarelli et al.
ONCOTARGET (2017)
Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
Clemence Granier et al.
ESMO OPEN (2017)
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
Lisa Zimmer et al.
EUROPEAN JOURNAL OF CANCER (2016)
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J. M. Michot et al.
EUROPEAN JOURNAL OF CANCER (2016)
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
Douglas B. Johnson et al.
JAMA ONCOLOGY (2016)
Acute visual loss after ipilimumab treatment for metastatic melanoma
Melissa A. Wilson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
Noha Abdel-Wahab et al.
PLOS ONE (2016)
Ipilimumab-Associated Bilateral Optic Neuropathy
Oliver L. Yeh et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2015)
Thyroid-Like Ophthalmopathy in a Euthyroid Patient Receiving Ipilimumab
Elizabeth McElnea et al.
ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY (2014)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Incidence and Prevalence of Uveitis Results From the Pacific Ocular Inflammation Study
Nisha R. Acharya et al.
JAMA OPHTHALMOLOGY (2013)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Risk of Relapse in Primary Acute Anterior Uveitis
Lili Grunwald et al.
OPHTHALMOLOGY (2011)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Incidence and Prevalence of Uveitis in Veterans Affairs Medical Centers of the Pacific Northwest
Eric B. Suhler et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Distinct sets of genetic alterations in melanoma
JA Curtin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Incidence and prevalence of uveitis in Northern California - The Northern California Epidemiology of Uveitis Study
DC Gritz et al.
OPHTHALMOLOGY (2004)
分享论文
